Aurora Cannabis Inc. (TSX: ACB)
ACB trades on the Toronto Stock Exchange in Life Sciences, headquartered in Alberta. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Close · October 14, 2026
C$5.93
-2.95% on the day
Market cap (C$)
C$365.4M
TMX list, September 30, 2026
Market cap (US$)
US$256.2M
Micro cap at 1.4263 C$/US$
1-year return
-20.0%
+2.8% year to date
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of September 30, 2026. US$ figures convert C$ at 1.4263 C$ per US$, the Bank of Canada daily rate for October 14, 2026. Close and returns: Yahoo Finance daily closes for ACB.TO, last bar 2026-10-14, computed by Sophia Capital. Website: Wikidata.
Profile
| Field | Value |
|---|---|
| Ticker | ACB on the Toronto Stock Exchange |
| Yahoo symbol | ACB.TO |
| Sector | Life Sciences, Cannabis |
| Headquarters | Alberta |
| Listed | 2017-07-24 |
| Listing type | TSXV Grad |
| Shares outstanding | 65,724,494 |
| Also listed on | NasdaqCM |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | 0001683541 |
| Website | auroramj.com |
| US listing | ACB |
Returns
| Window | Return |
|---|---|
| 1 day | -2.9% |
| 1 week | -8.9% |
| 1 month | +11.9% |
| 3 months | +57.7% |
| 6 months | +21.3% |
| Year to date | +2.8% |
| 1 year | -20.0% |
| From 52-week high | -25.1% |
| 52-week range | C$3.64 to C$7.92 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
121 documents in 12 types. Each title links to the document at its source.
Annual financial statements (2)
| Document | Type | Filed |
|---|---|---|
| Audited consolidated financial statements of the Company and notes thereto as at and for the financial year ended March 31, 2026, together with the… Period 2026-03-31 | Annual financial statements (40-F) | 2026-06-11 |
| Audited consolidated financial statements of the Company and notes thereto as at and for the financial year ended March 31, 2025, together with the… Period 2025-03-31 | Annual financial statements (40-F) | 2025-06-18 |
Interim financial statements (6)
| Document | Type | Filed |
|---|---|---|
| Condensed Consolidated Interim Financial Statements for the three months ended June 30, 2026 and 2025 Period 2026-06-30 | Interim financial statements (6-K) | 2026-08-05 |
| Condensed Consolidated Interim Financial Statements for the three and nine months ended December 31, 2025 and 2024 Period 2025-12-31 | Interim financial statements (6-K) | 2026-02-04 |
| Condensed Consolidated Interim Financial Statements for the three and six months ended September 30, 2025 and 2024 Period 2025-09-30 | Interim financial statements (6-K) | 2025-11-05 |
| Condensed Consolidated Interim Financial Statements for the three months ended June 30, 2025 and 2024 Period 2025-06-30 | Interim financial statements (6-K) | 2025-08-06 |
MD&A (8)
| Document | Type | Filed |
|---|---|---|
| Management’s Discussion and Analysis for the financial year ended March 31, 2026 Period 2026-03-31 | MD&A (annual) (40-F) | 2026-06-11 |
| Management’s Discussion and Analysis for the financial year ended March 31, 2025 Period 2025-03-31 | MD&A (annual) (40-F) | 2025-06-18 |
| Interim Management’s Discussion and Analysis for the three months ended June 30, 2026 and 2025 Period 2026-06-30 | MD&A (interim) (6-K) | 2026-08-05 |
| Interim Management’s Discussion and Analysis for the three and nine months ended December 31, 2025 and 2024 Period 2025-12-31 | MD&A (interim) (6-K) | 2026-02-04 |
Annual information form (2)
| Document | Type | Filed |
|---|---|---|
| Annual Information Form of the Company for the financial year ended March 31, 2026 Period 2026-03-31 | Annual information form (40-F) | 2026-06-11 |
| Annual Information Form of the Company for the financial year ended March 31, 2025 Period 2025-03-31 | Annual information form (40-F) | 2025-06-18 |
Material change report (3)
| Document | Type | Filed |
|---|---|---|
| MATERIAL CHANGE REPORT | Material change report (6-K) | 2026-04-16 |
| Material Change Report | Material change report (6-K) | 2026-02-12 |
| Material Change Report | Material change report (6-K) | 2026-02-12 |
News release (52)
| Document | Type | Filed |
|---|---|---|
| NEWS RELEASE DATED OCTOBER 14, 2026 | News release (6-K) | 2026-10-14 |
| NEWS RELEASE DATED OCTOBER 8, 2026 | News release (6-K) | 2026-10-08 |
| NEWS RELEASE DATED OCTOBER 6, 2026 | News release (6-K) | 2026-10-07 |
| NEWS RELEASE DATED OCTOBER 5, 2026 | News release (6-K) | 2026-10-06 |
Management information circular / proxy (9)
| Document | Type | Filed |
|---|---|---|
| MANAGEMENT INFORMATION CIRCULAR | Management information circular (6-K) | 2026-07-09 |
| MANAGEMENT INFORMATION CIRCULAR | Management information circular (6-K) | 2025-07-09 |
| Notice of Annual General Meeting of Shareholders and Availability of Proxy Materials | Notice of meeting (6-K) | 2026-07-09 |
| NOTICE OF MEETING AND RECORD DATE | Notice of meeting (6-K) | 2026-05-21 |
Report of voting results (2)
| Document | Type | Filed |
|---|---|---|
| VOTING RESULTS | Report of voting results (6-K) | 2026-08-10 |
| REPORT ON VOTING RESULTS | Report of voting results (6-K) | 2025-08-11 |
Prospectus (3)
| Document | Type | Filed |
|---|---|---|
| F-10 | Prospectus (short form) (F-10) | 2025-02-14 |
| SUPPL | Prospectus supplement (SUPPL) | 2026-02-04 |
| SUPPL | Prospectus supplement (SUPPL) | 2025-02-14 |
Annual report (2)
| Document | Type | Filed |
|---|---|---|
| 40-F Period 2026-03-31 | Annual report (40-F) (40-F) | 2026-06-11 |
| 40-F Period 2025-03-31 | Annual report (40-F) (40-F) | 2025-06-18 |
Certification (20)
| Document | Type | Filed |
|---|---|---|
| Certification of Chief Executive Officer | Certification (52-109) (6-K) | 2026-08-05 |
| Certification of Chief Financial Officer | Certification (52-109) (6-K) | 2026-08-05 |
| Certification of Chief Executive Officer | Certification (52-109) (6-K) | 2026-02-04 |
| Certification of Chief Financial Officer | Certification (52-109) (6-K) | 2026-02-04 |
Other (12)
| Document | Type | Filed |
|---|---|---|
| Consent of Ernst & Young LLP Period 2026-03-31 | Consent (40-F) | 2026-06-11 |
| Consent of Stikeman Elliot LLP | Consent (6-K) | 2026-02-04 |
| Consent of KPMG LLP Period 2025-03-31 | Consent (40-F) | 2025-06-18 |
| Consent of Ernst & Young LLP Period 2025-03-31 | Consent (40-F) | 2025-06-18 |
Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
Trading: the last notice, on 2026-08-11, was a resumption.
| Notice | Action | Reason | Notice |
|---|---|---|---|
| 2026-08-11 3:45 PM ET | Resumption | No reason stated | CIRO notice |
| 2026-08-11 12:05 PM ET | Halt | Pending News | CIRO notice |
| 2026-04-22 11:51:02 ET | Halt | Single Stock Circuit Breaker | CIRO notice |
| 2026-04-22 11:56:02 AM ET | Resumption | No reason stated | CIRO notice |
| 2025-06-02 12:00 PM ET | Halt | Pending Delisting | CIRO notice |
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2016-08-31 | Equity | US$51K | US$51K | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| CPH | Cipher Pharmaceuticals Inc. | TSX | C$346.0M | -9.6% | -6.3% |
| EDT | Spectral Medical Inc. | TSX | C$335.9M | -14.0% | -20.7% |
| PRN | Profound Medical Corp. | TSX | C$304.9M | +17.1% | +17.5% |
| PAIN | Vector Science and Therapeutics Corp. | TSXV | C$300.3M | -18.4% | Under a year of closes |
| CRDL | Cardiol Therapeutics Inc. | TSX | C$281.9M | -42.2% | +9.6% |
The app has the price chart, every filing, private raises and the full peer set for ACB.
Open in the app